Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
24.34
-0.34 (-1.36%)
At close: Nov 14, 2025, 4:00 PM EST
23.93
-0.41 (-1.66%)
After-hours: Nov 14, 2025, 7:35 PM EST
Rapport Therapeutics Market Cap
Rapport Therapeutics has a market cap or net worth of $1.16 billion as of November 14, 2025. Its market cap has increased by 18.31% in one year.
Market Cap
1.16B
Enterprise Value
660.35M
1-Year Change
18.31%
Ranking
Category
Stock Price
$24.34
Market Cap Chart
Since the IPO on June 7, 2024, Rapport Therapeutics's market cap has increased from $601.40M to $1.16B, an increase of 93.13%. That is a compound annual growth rate of 58.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 1.16B | 79.00% |
| Dec 31, 2024 | 648.87M | 7.89% |
| Jun 7, 2024 | 601.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 916.57B |
| Johnson & Johnson | 470.78B |
| AbbVie | 412.71B |
| UnitedHealth Group | 301.50B |
| AstraZeneca | 276.17B |
| Novartis AG | 256.16B |
| Merck & Co. | 230.96B |
| Abbott Laboratories | 224.66B |